Cannabis and cannabinoid receptors
- PMID: 10930707
- DOI: 10.1016/s0367-326x(00)00171-4
Cannabis and cannabinoid receptors
Abstract
Cannabis and cannabinoids exert many of their biological functions through receptor-mediated mechanisms. Two types of cannabinoid receptors have been identified, namely CB(1) and CB(2), both coupled to a G protein. CB(1) receptors have been detected in the central nervous system (where they are responsible for the characteristic effects of Cannabis, including catalepsy, depression of motor activity, analgesia and feelings of relaxation and well being) and in peripheral neurons (where their activation produces a suppression in neurotransmitter release in the heart, bladder, intestine and vas deferens). Cannabinoid CB(2) receptors have only been detected outside the central nervous system, mostly in cells of the immune system, presumably mediating cannabinoid-induced immunosuppression and antinflammatory effects. With the discovery of cannabinoid receptors for exogenous cannabinoids, also endogenous cannabinoids (anandamide, 2-arachidonylglycerol) have been described.
Similar articles
-
Cannabis and cannabinoids: pharmacology and rationale for clinical use.Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. doi: 10.1159/000057150. Forsch Komplementarmed. 1999. PMID: 10575283 Review.
-
Cannabis and the brain.Brain. 2003 Jun;126(Pt 6):1252-70. doi: 10.1093/brain/awg143. Brain. 2003. PMID: 12764049 Review.
-
Cannabinoids.Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. doi: 10.2174/156800705774322111. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16266285 Review.
-
Cannabinoid modulation of peripheral autonomic and sensory neurotransmission.Eur J Pharmacol. 2003 Jul 4;472(1-2):1-21. doi: 10.1016/s0014-2999(03)01813-2. Eur J Pharmacol. 2003. PMID: 12860468 Review.
-
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.Expert Opin Investig Drugs. 2000 Jul;9(7):1553-71. doi: 10.1517/13543784.9.7.1553. Expert Opin Investig Drugs. 2000. PMID: 11060760 Review.
Cited by
-
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation.J Mol Med (Berl). 2007 Jun;85(6):635-45. doi: 10.1007/s00109-007-0188-z. Epub 2007 Apr 20. J Mol Med (Berl). 2007. PMID: 17447045
-
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.Psychopharmacology (Berl). 2005 Jan;177(3):264-71. doi: 10.1007/s00213-004-1941-4. Epub 2004 Jul 28. Psychopharmacology (Berl). 2005. PMID: 15290008
-
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.J Pharmacol Exp Ther. 2016 Jun;357(3):537-44. doi: 10.1124/jpet.116.232553. Epub 2016 Mar 21. J Pharmacol Exp Ther. 2016. PMID: 27000802 Free PMC article.
-
Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review.Curr Drug Res Rev. 2025;17(2):160-169. doi: 10.2174/0125899775273727231224185028. Curr Drug Res Rev. 2025. PMID: 40761110 Free PMC article. Review.
-
Sigma receptors [σRs]: biology in normal and diseased states.J Recept Signal Transduct Res. 2016 Aug;36(4):327-388. doi: 10.3109/10799893.2015.1015737. Epub 2015 Jun 9. J Recept Signal Transduct Res. 2016. PMID: 26056947 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical